Source: Wired
by John Semley
“About this time last year, prescription MDMA looked like a sure thing. After decades of clinical research, political wrangling, and aggressive promotion, the popular underground club drug was set to be tamed and medicalized, with a stamp of approval from the US Food and Drug Administration. Then, it wasn’t. In a stark change of course, the FDA rejected the MDMA therapy it had been considering by a 10-1 vote. The decision derailed psychedelic medicine for the foreseeable future. Except for one thing — an unexpected lifeline from the Trump administration.” (07/29/25)